Syndecan-4 (SDC4) (SDC4)

Syndecan-4 (SDC4) is a transmembrane heparan sulfate proteoglycan (HSPG) that acts as a central regulator of the cell surface microenvironment by facilitating interactions between the extracellular matrix and the intracellular signaling machinery (UniProt P31431). It is uniquely characterized by its ability to activate protein kinase C alpha (PKCα) and its role as a co-receptor for various growth factors and cytokines (PubMed 10449570). In the context of fibrinolysis, Syndecan-4 utilizes its heparan sulfate (HS) chains to bind and concentrate key components of the fibrinolytic system, such as plasminogen and tissue plasminogen activator (tPA), on the cell surface, thereby accelerating plasmin generation and fibrin degradation (PubMed 12050160). This pathway is essential for maintaining vascular integrity and preventing pathological fibrin deposition (PubMed 25663614). Dysregulation of this pathway is implicated in cardiovascular diseases, chronic inflammatory conditions, and impaired wound healing, where the loss of SDC4-mediated fibrinolysis contributes to tissue fibrosis (PubMed 19103911). While no drugs specifically targeting Syndecan-4 are currently approved, therapeutic research focuses on using heparan sulfate mimetics and experimental monoclonal antibodies designed to modulate its ligand-binding properties or signaling activities.

Other names

SYND4AmphiglycanRyudocanProteoglycan 4

Modulation of heparan sulfate-ligand interactions to regulate cell surface protease activity and signal transduction.